BiotechTube
Home/Insulet/Michael Levitz
ML

Michael Levitz

EVP & Chief Financial Officer

Insulet

Therapeutic Areas

DiabetesMetabolic Disorders

Insulet Pipeline

DrugIndicationPhase
Omnipod 5 SystemType 1 & Type 2 Diabetes (Automated Insulin Delivery)Approved/Commercial
Omnipod GOType 2 Diabetes (Basal Insulin Delivery)Approved/Commercial
Platform Algorithm Updates & CGM IntegrationsDiabetesDevelopment

Leadership Team at Insulet

JH
Jim Hollingshead, Ph.D.
President & Chief Executive Officer
LC
Laetitia Cousin
EVP & Chief Commercial Officer
DT
Dr. Trang Ly
SVP & Medical Director
View full Insulet profile